Product Information

AMLODIPINE-OLMESARTAN 10-20 MG is a generic product labeled by Micro Labs Limited, priced at $0.2298 per EA under NDC 42571023690. Its NADAC has been published 324 times since Jun 10, 2020.

FDA first approved this application on Nov 2, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-OLMESARTAN 10-20 MG

Amlodipine and Olmesartan Medoxomil
$0.2298per EA

Strength

10; 20 mg/1; mg/1

Manufacturer

Micro Labs Limited

NDC

42571023690

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207435

FDA Approved

11/2/2017

TE Code

AB

On Market Since

1/1/2018

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has been published 324 times since Jun 10, 2020, and over the history we have for it it has declined 71.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2298 per EA
All-time high$0.8835 (Aug 12, 2020)
All-time low$0.2298 (Aug 19, 2026)
52-week high$0.3713
52-week low$0.2298
Median price$0.3759
Average price$0.4015
Largest weekly change+68.6% (Nov 22, 2023)
Weeks tracked324
Tracking sinceJun 10, 2020

Price History

1W

-4.3%

1M

-4.3%

3M

-22.2%

6M

-27.6%

1Y

-38.1%

3Y

-49.7%

5Y

-59.2%

All

-71.1%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 10-20 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-20 MG, manufactured by Micro Labs Limited, is $0.2298 per EA (NDC 42571023690), effective Aug 19, 2026.

How has the price of AMLODIPINE-OLMESARTAN 10-20 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has declined 71.1%. It has been tracked across 324 weekly CMS publications since Jun 10, 2020.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-20 MG?

Since Jun 10, 2020, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has ranged from a low of $0.2298 (Aug 19, 2026) to a high of $0.8835 (Aug 12, 2020), with a median of $0.3759 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-20 MG?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 10-20 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 10-20 MG?

AMLODIPINE-OLMESARTAN 10-20 MG (NDC 42571023690) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.